1. 2500 Orteronel (Ort) maintenance therapy in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) and non-progressive disease after first-line docetaxel (Doc) therapy: Results of a multicenter randomized double-blind placebo-controlled phase III trial (SAKK 08/11). Issue 3 (September 2015) Authors: Cathomas, R.; Crabb, S.; Kenner, H.; Mark, M.; Rothermundt, C.; Elliott, T.; Winterhalder, R.; Von Burg, P.; Berardi Vilei, S.; Hayoz, S.; Rauch, D.; Roggero, E.; Stenner, F.; Berthold, D.; Erdmann, A.; Fischer, N.; Manetsch, G.; Gillessen, S. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. Issue 5 (May 2021) Authors: Petit, Claire; Lacas, Benjamin; Pignon, Jean-Pierre; Le, Quynh Thu; Grégoire, Vincent; Grau, Cai; Hackshaw, Allan; Zackrisson, Björn; Parmar, Mahesh K B; Lee, Ju-Whei; Ghi, Maria Grazia; Sanguineti, Giuseppe; Temam, Stéphane; Cheugoua-Zanetsie, Maurice; O'Sullivan, Brian; Posner, Marshall R; Voke... Journal: Lancet oncology Issue: Volume 22:Issue 5(2021) Page Start: 727 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. INTEGRATION BETWEEN METABOLIC TUMOUR VOLUME AND METABOLIC HETEROGENEITY PREDICTS OUTCOME OF DLBCL LYMPHOMA PATIENTS IN THE SAKK 38/07 STUDY COHORT. (12th June 2019) Authors: Ceriani, L.; Pirosa, M.; Stathis, A.; Gritti, G.; Ruberto, T.; Bruno, A.; Moccia, A.; Rambaldi, A.; Ferrari, S.; Giovannella, L.; Hayoz, S.; Mazzucchelli, L.; Dirnhofer, S.; Mamot, C.; Zucca, E. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19, 805 patients, on behalf of MACH-NC Group. (March 2021) Authors: Lacas, Benjamin; Carmel, Alexandra; Landais, Cécile; Wong, Stuart J.; Licitra, Lisa; Tobias, Jeffrey S.; Burtness, Barbara; Ghi, Maria Grazia; Cohen, Ezra E.W.; Grau, Cai; Wolf, Gregory; Hitt, Ricardo; Corvò, Renzo; Budach, Volker; Kumar, Shaleen; Laskar, Sarbani Ghosh; Mazeron, Jean-Jacques; Zho... Journal: Radiotherapy and oncology Issue: Volume 156(2021) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC-0125: Relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 trial. (May 2017) Authors: Ghadjar, P.; Hayoz, S.; Genitsch, V.; Zwahlen, D.; Hölscher, T.; Gut, P.; Guckenberger, M.; Hildebrandt, G.; Müller, A.C.; Putora, M.; Papachristofilou, A.; Stalder, L.; Biaggi-Rudolf, C.; Sumila, M.; Kranzbühler, H.; Najafi, Y.; Ost, P.; Azinwi, N.; Reuter, C.; Bodis, S. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC-0949 Improved sparing of liver and lung tissue: DIBH for right breast irradiation. (May 2022) Authors: Pace, R.; Boucas da Silva, R.T.; Adam, L.E.J.; Näf, G.; Winter, C.; Aspradakis, M.M.; Hayoz, S.; Baumert, B.G. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S841 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PREDICTIVE VALUE OF POD24 VALIDATION IN FOLLICULAR LYMPHOMA PATIENTS INITIALLY TREATED WITH CHEMOTHERAPY‐FREE REGIMENS IN A POOLED ANALYSIS OF THREE RANDOMIZED TRIALS OF THE SWISS GROUP FOR CLINICAL CANCER RESEARCH (SAKK). (12th June 2019) Authors: Moccia, A.; Schär, S.; Hayoz, S.; Pirosa, M.; Taverna, C.; Novak, U.; Kimby, E.; Ghielmini, M.; Zucca, E. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PROGNOSTIC IMPLICATIONS OF THE MICROENVIRONMENT IN FOLLICULAR LYMPHOMA UNDER RITUXIMAB AND RITUXIMAB+LENALIDOMIDE THERAPY. A TRANSLATIONAL STUDY OF THE SAKK35/10 TRIAL. (12th June 2019) Authors: Menter, T.; Tzankov, A.; Zucca, E.; Kimby, E.; Vanazzi, A.; Østenstad, B.; Mey, U.J.; Rauch, D.; Wahlin, B.; Hitz, F.; Hernberg, M.; Johansson, A.; de Nully Brown, P.; Hagberg, H.; Hawle, H.; Hayoz, S.; Dirnhofer, S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SAKK 35/15: A PHASE I TRIAL OF OBINUTUZUMAB IN COMBINATION WITH VENETOCLAX IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA PATIENTS. (12th June 2019) Authors: Stathis, A.; Mey, U.; Schär, S.; Hitz, F.; Pott, C.; Mach, N.; Krasniqi, F.; Novak, U.; Schmidt, C.; Hohloch, K.; Kienle, D.; Hess, D.; Moccia, A.; Unterhalt, M.; Eckhardt, K.; Hayoz, S.; Rossi, D.; Dirnhofer, S.; Ceriani, L.; Bertoni, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗